Therapeutic Antibodi - Directors Shareholding

RNS No 9374w
THERAPEUTIC ANTIBODIES INC
19th December 1997


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
STEVEN L. STROUP M.D.

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR IN (2) ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
STEVEN L. STROUP M.D.

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
N/A

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
RECEIPT OF OPTIONS

7   Number of shares/amount of stock acquired:
N/A

8   Percentage of issued class:
N/A

9   Number of shares/amount of stock disposed:
N/A

10  Percentage of issued class:
N/A

11  Class of security:
SHARES OF COMMON STOCK $0.001 PER SHARE

12  Price per share:
N/A

13  Date of transaction:
18 DECEMBER, 1997

14  Date company informed:
18 DECEMBER, 1997

15  Total holding following this notification:
1) OPTIONS/WARRANTS TO SUBSCRIBE FOR SHS OF COMMON STK- 56,500  2) 379,200 SHS


16  Total percentage holding of issued class following this notification:
1) .0024           2) .016

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
18 DECEMBER, 1997

18  Period during which or date on which exercisable:
18 DECEMBER, 1997

19  Total amount paid (if any) for grant of the option:
N/A

20  Description of shares or debentures involved: class, number:
7,500 SHS OF COMMON STOCK

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
$4.06

22  Total number of shares or debentures over which options held following
this notification:
42,500

23  Contact name for queries:
MICHAEL HAMBLIN
ASSISTANT COMPANY SECRETARY

24  Contact telephone number:
0171 606 8637

25  Name of company official responsible for making notification:
J. RONALD OPENSHAW


END

RDSOCCCQPDDDFBD